Patents Assigned to NANOSOMIX, INC.
  • Biomarkers and diagnostic methods for Alzheimer's disease and other neurodegenerative disorders
    Patent number: 11619637
    Abstract: The present invention relates to biomarkers and diagnostic and prognostic methods for Alzheimer's disease and other neurodegenerative disorders. The invention also provides compositions for detecting the biomarker as well as compositions and methods useful for treating Alzheimer's disease and other neurodegenerative disorders.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: April 4, 2023
    Assignee: NanoSomiX, Inc.
    Inventor: Edward J. Goetzl
  • SYNAPTIC PROTEIN BIOMARKERS AND DIFFERENTIAL DIAGNOSIS OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
    Publication number: 20200309791
    Abstract: The present invention relates to synaptic protein biomarkers and diagnostic and prognostic methods for Alzheimer's disease and other neurodegenerative disorders. The invention also provides compositions for detecting the synaptic protein biomarkers as well as compositions and methods useful for early diagnosis and/or treatment of Alzheimer's disease and other neurodegenerative disorders. The invention also provides methods for detecting biomarkers in vesicles (e.g., exosomes) isolated from a biological sample.
    Type: Application
    Filed: May 7, 2017
    Publication date: October 1, 2020
    Applicant: Nanosomix, Inc.
    Inventor: Edward J GOETZL
  • QUANTIFICATION OF SUBPOPULATIONS OF EXOSOMES AND DIAGNOSIS OF NEUROGENERATIVE DISORDERS
    Publication number: 20190361037
    Abstract: The present invention relates to methods for quantifying subpopulations of exosomes and diagnostic and prognostic methods for neurodegenerative disorders (e.g., Alzheimer's disease). The invention also provides compositions for quantifying subpopulations of exosomes as well as compositions and methods useful for treating Alzheimer's disease and other neurodegenerative disorders.
    Type: Application
    Filed: November 16, 2017
    Publication date: November 28, 2019
    Applicant: Nanosomix, Inc.
    Inventor: Masato J Mitsuhashi
  • Biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disorders
    Patent number: 10203342
    Abstract: The present invention relates to biomarkers and diagnostic and prognostic methods for Alzheimer's disease and other neurodegenerative disorders. The invention also provides compositions for detecting the biomarker as well as compositions and methods useful for treating Alzheimer's disease and other neurodegenerative disorders.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: February 12, 2019
    Assignee: NANOSOMIX, INC.
    Inventor: Edward J. Goetzl
  • Biomarkers and diagnostic methods for Alzheimer's disease and other neurodegenerative disorders
    Patent number: 9958460
    Abstract: The present invention relates to biomarkers and diagnostic and prognostic methods for Alzheimer's disease and other neurodegenerative disorders. The invention also provides compositions for detecting the biomarker as well as compositions and methods useful for treating Alzheimer's disease and other neurodegenerative disorders.
    Type: Grant
    Filed: October 24, 2014
    Date of Patent: May 1, 2018
    Assignee: NANOSOMIX, INC.
    Inventor: Edward J. Goetzl